Aller au contenu

Interactions médicamenteuses

Abiraterone + Selexipag

Gravité: Modérée

Abiraterone and Selexipag: moderate interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Abiraterone inhibits CYP2C8, which metabolizes selexipag and its active metabolite. Exposure may rise, increasing adverse effects such as headache, diarrhea and hypotension.

Ce que signifie cette interaction, en termes simples

Abiraterone and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Abiraterone belongs to Endocrine; Selexipag belongs to Cardiovascular.

Niveau de preuve: Low

Pourquoi elle survient

Abiraterone inhibits CYP2C8-mediated metabolism of selexipag.

Conduite à tenir

Monitor for selexipag adverse effects and consider reducing selexipag to once daily, as recommended with moderate CYP2C8 inhibitors.

Questions à poser à votre pharmacien

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Abiraterone et Selexipag, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.

Questions fréquentes

Can I take Abiraterone with Selexipag?

MediHelp rates the interaction as moderate. Abiraterone and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Abiraterone inhibits CYP2C8, which metabolizes selexipag and its active metabolite. Exposure may rise, increasing adverse effects such as headache, diarrhea and hypotension.

How serious is the interaction between Abiraterone and Selexipag?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for selexipag adverse effects and consider reducing selexipag to once daily, as recommended with moderate CYP2C8 inhibitors.

What other medicines interact with Abiraterone?

MediHelp also lists interactions of Abiraterone with, for example, Radium-223 dichloride, Thioridazine, Amobarbital. The full list is on the Abiraterone page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter